デフォルト表紙
市場調査レポート
商品コード
920471

世界の喘息治療市場:産業分析、規模、シェア、成長、動向、および予測(2019年~2027年)

Asthma Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

出版日: | 発行: Transparency Market Research | ページ情報: 英文 213 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.41円
世界の喘息治療市場:産業分析、規模、シェア、成長、動向、および予測(2019年~2027年)
出版日: 2019年10月12日
発行: Transparency Market Research
ページ情報: 英文 213 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは世界の喘息治療市場について調査しており、市場機会、成長および阻害要因、治療タイプ・投与経路・流通チャネル・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 序文

  • 市場の定義・範囲
  • 市場セグメンテーション
  • 主な調査目的
  • 調査ハイライト

第2章 前提条件・調査方法

第3章 エグゼクティブサマリー

第4章 市場の概要

  • イントロダクション
  • 概要
  • 市場力学
    • 成長要因
    • 阻害要因
    • 市場機会
  • 市場分析・予測

第5章 市場の見通し

  • パイプライン分析
  • 償還シナリオ
  • 主要国の有病率

第6章 市場分析:治療タイプ別

  • 概要・定義
  • 主な調査結果/開発
  • 市場売上予測
    • 長期喘息制御薬
    • クイックリリーフ薬(レスキュー薬)
  • 市場の魅力

第7章 市場分析:投与経路別

  • 概要・定義
  • 主な調査結果/開発
  • 市場売上予測
    • 経口
    • 吸入
    • 静脈内
    • 皮下
  • 市場の魅力

第8章 市場分析:流通チャネル別

  • 概要・定義
  • 主な調査結果/開発
  • 市場売上予測
    • 病院薬局
    • 小売薬局
    • オンライン薬局
  • 市場の魅力

第9章 市場分析:地域別

  • 主な調査結果
  • 市場売上予測
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力

第10章 北米

第11章 欧州

第12章 アジア太平洋地域

第13章 ラテンアメリカ

第14章 中東・アフリカ

第15章 競合情勢

  • 市場シェア分析:企業別
  • 企業プロファイル
    • AstraZeneca
    • Boehringer Ingelheim International GmbH
    • GlaxoSmithKline plc
    • Novartis AG
    • Teva Pharmaceutical Industries Ltd
    • 大日本住友製薬株式会社
    • Merck & Co., Inc.
    • F. Hoffmann-La Roche Ltd.
    • Sanofi
    • Mylan NV
図表

List of Tables

  • Table 01: Pipeline Analysis
  • Table 02: Pipeline Analysis
  • Table 03: Pipeline Analysis
  • Table 04: Global Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017-2027
  • Table 05: Global Asthma Treatment Market Value (US$ Mn) Forecast, by Long-term Asthma Control Medications, 2017-2027
  • Table 06: Global Asthma Treatment Market Value (US$ Mn) Forecast, by Quick-relief (rescue) Medications, 2017-2027
  • Table 07: Global Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
  • Table 08: Global Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 09: Global Asthma Treatment Market Value (US$ Mn) Forecast, by Region, 2017-2027
  • Table 10: North America Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017-2027
  • Table 11: North America Asthma Treatment Market Value (US$ Mn) Forecast, by Long-term Asthma Control Medications, 2017-2027
  • Table 12: North America Asthma Treatment Market Value (US$ Mn) Forecast, by Quick-relief (rescue) Medications, 2017-2027
  • Table 13: North America Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
  • Table 14: North America Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 15: North America Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 16: Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017-2027
  • Table 17: Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Long-term Asthma Control Medications, 2017-2027
  • Table 18: Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Quick-relief (rescue) Medications, 2017-2027
  • Table 19: Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
  • Table 20: Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 21: Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 22: Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017-2027
  • Table 23: Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Long-term Asthma Control Medications, 2017-2027
  • Table 24: Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Quick-relief (rescue) Medications, 2017-2027
  • Table 25: Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
  • Table 26: Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 27: Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 28: Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017-2027
  • Table 29: Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Long-term Asthma Control Medications, 2017-2027
  • Table 30: Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Quick-relief (rescue) Medications, 2017-2027
  • Table 31: Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
  • Table 32: Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 33: Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 34: Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017-2027
  • Table 35: Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Long-term Asthma Control Medications, 2017-2027
  • Table 36: Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Quick-relief (rescue) Medications, 2017-2027
  • Table 37: Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
  • Table 38: Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 39: Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

List of Figures

  • Figure 01: Global Asthma Treatment Market Value (US$ Mn) and Distribution Channel, by Region, 2018 and 2027
  • Figure 02: Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 03: Global Asthma Treatment Market Value Share Analysis, by Treatment Type, 2018 and 2027
  • Figure 04: Global Asthma Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), by Long-term Asthma Control Medications, 2017-2027
  • Figure 05: Global Asthma Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), by Quick-relief (rescue) Medications, 2017-2027
  • Figure 06: Global Asthma Treatment Market Attractiveness Analysis, by Treatment Type, 2019-2027
  • Figure 07: Global Asthma Treatment Market Value Share Analysis, by Route of Administration, 2018 and 2027
  • Figure 08: Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Inhaled, 2017-2027
  • Figure 09: Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Oral, 2017-2027
  • Figure 10: Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Intravenous, 2017-2027
  • Figure 11: Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Subcutaneous, 2017-2027
  • Figure 12: Global Asthma Treatment Market Attractiveness Analysis, by Route of Administration, 2019-2027
  • Figure 13: Global Asthma Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 14: Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Retail Pharmacies, 2017-2027
  • Figure 15: Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital Pharmacies, 2017-2027
  • Figure 16: Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Online Pharmacies, 2017-2027
  • Figure 17: Global Asthma Treatment Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 18: Global Asthma Treatment Market Value Share Analysis, by Region, 2018 and 2027
  • Figure 19: Global Asthma Treatment Market Attractiveness Analysis, by Region, 2019-2027
  • Figure 20: North America Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 21: North America Asthma Treatment Market Value Share Analysis, by Treatment Type, 2018 and 2027
  • Figure 22: North America Asthma Treatment Market Attractiveness Analysis, by Treatment Type, 2019-2027
  • Figure 23: North America Asthma Treatment Market Value Share Analysis, by Route of Administration, 2018 and 2027
  • Figure 24: North America Asthma Treatment Market Attractiveness Analysis, by Route of Administration, 2019-2027
  • Figure 25: North America Asthma Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 26: North America Asthma Treatment Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 27: North America Asthma Treatment Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 28: North America Asthma Treatment Market Attractiveness Analysis, by Country, 2019-2027
  • Figure 29: Europe Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 30: Europe Asthma Treatment Market Value Share Analysis, by Treatment Type, 2018 and 2027
  • Figure 31: Europe Asthma Treatment Market Attractiveness Analysis, by Treatment Type, 2019-2027
  • Figure 32: Europe Asthma Treatment Market Value Share Analysis, by Route of Administration, 2018 and 2027
  • Figure 33: Europe Asthma Treatment Market Attractiveness Analysis, by Route of Administration, 2019-2027
  • Figure 34: Europe Asthma Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 35: Europe Asthma Treatment Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 36: Europe Asthma Treatment Market Value Share Analysis, by Country/Sub-Region, 2018 and 2027
  • Figure 37: Europe Asthma Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 38: Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 39: Asia Pacific Asthma Treatment Market Value Share Analysis, by Treatment Type, 2018 and 2027
  • Figure 40: Asia Pacific Asthma Treatment Market Attractiveness Analysis, by Treatment Type, 2017-2027
  • Figure 41: Asia Pacific Asthma Treatment Market Value Share Analysis, by Route of Administration, 2018 and 2027
  • Figure 42: Asia Pacific Asthma Treatment Market Attractiveness Analysis, by Route of Administration, 2019-2027
  • Figure 43: Asia Pacific Asthma Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 44: Asia Pacific Asthma Treatment Market Attractiveness Analysis, by Distribution Channel, 2019 - 2027
  • Figure 45: Asia Pacific Asthma Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 46: Asia Pacific Asthma Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 47: Latin America Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 48: Latin America Asthma Treatment Market Value Share Analysis, by Treatment Type, 2018 and 2027
  • Figure 49: Latin America Asthma Treatment Market Attractiveness Analysis, by Treatment Type, 2019-2027
  • Figure 50: Latin America Asthma Treatment Market Value Share Analysis, by Route of Administration, 2018 and 2027
  • Figure 51: North America Asthma Treatment Market Attractiveness Analysis, by Route of Administration, 2019-2027
  • Figure 52: Latin America Asthma Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 53: Latin America Asthma Treatment Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 54: Latin America Asthma Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 55: Latin America Asthma Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 56: Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 57: Middle East & Africa Asthma Treatment Market Value Share Analysis, by Treatment Type, 2018 and 2027
  • Figure 58: Middle East & Africa Asthma Treatment Market Attractiveness Analysis, by Treatment Type, 2019-2027
  • Figure 59: Middle East & Africa Asthma Treatment Market Value Share Analysis, by Route of Administration, 2018 and 2027
  • Figure 60: Middle East & Africa Asthma Treatment Market Attractiveness Analysis, by Route of Administration, 2019-2027
  • Figure 61: Middle East & Africa Asthma Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 62: Middle East & Africa Asthma Treatment Market Attractiveness Analysis, by Distribution Channel, 2019?2027
  • Figure 63: Middle East & Africa Asthma Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 64: Middle East & Africa Asthma Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 65: Global Asthma Treatment Market Share, by Company, 2018
  • Figure 66: AstraZeneca Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 67: AstraZeneca Respiratory Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 68: AstraZeneca Breakdown of Net Sales (%), by Product Segment, 2018
  • Figure 69: Boehringer Ingelheim International GmbH Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 70: Boehringer Ingelheim International GmbH Breakdown of Net Sales (%), by Region, 2018
  • Figure 71: Boehringer Ingelheim International GmbH R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 72: Boehringer Ingelheim International GmbH Breakdown of Net Sales (%), by Business Segment, 2018
  • Figure 73: GlaxoSmithKline plc Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 74: GlaxoSmithKline plc Breakdown of Net Sales (%), by Region, 2018
  • Figure 75: GlaxoSmithKline plc R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 76: GlaxoSmithKline plc Breakdown of Net Sales (%), by Business Segment, 2018
  • Figure 77: Novartis AG Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 78: Novartis AG Breakdown of Net Sales (%), by Country, 2018
  • Figure 79: Novartis AG R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 80: Novartis AG Breakdown of Net Sales (%), by Business Segment, 2018
  • Figure 81: Teva Pharmaceutical Industries Ltd Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 82: Teva Pharmaceutical Industries Ltd R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 83: Teva Pharmaceutical Industries Ltd Breakdown of Net Sales (%), by Segment, 2018
  • Figure 84: Sumitomo Dainippon Pharma Co., Ltd Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2017
  • Figure 85: Sumitomo Dainippon Pharma Co., Ltd Breakdown of Pharmaceutical Net Sales (%), by Region, 2017
  • Figure 86: Sumitomo Dainippon Pharma Co., Ltd R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014-2017
  • Figure 87: Breakdown of Sumitomo Dainippon Pharma Co., Ltd Net Sales (%), by Product Segment, 2017
  • Figure 88: Merck & Co., Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 89: Merck & Co., Inc. Breakdown of Net Sales (%), by Region, 2018
  • Figure 90: Merck & Co., Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 91: Merck & Co., Inc. Breakdown of Net Sales (%), by Business Segment, 2018
  • Figure 92: F. Hoffmann-La Roche Ltd. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 93: F. Hoffmann-La Roche Ltd. Breakdown of Net Sales (%), by Region, 2018
  • Figure 94: F. Hoffmann-La Roche Ltd. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 95: F. Hoffmann-La Roche Ltd. Breakdown of Net Sales (%), by Business Segment, 2018
  • Figure 96: Sanofi Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 97: Sanofi Breakdown of Net Sales (%), by Region, 2018
  • Figure 98: Sanofi Revenue Breakdown of Net Sales (%), by Business segment, 2018
  • Figure 99: Sanofi R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 100: Mylan N.V. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 101: Mylan N.V. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 102: Mylan N.V. Breakdown of Net Sales (%), by Region, 2018
目次

Asthma Treatment Market - Scope of the Report

TMR's report on the global asthma treatment market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators for the said market during the forecast period of 2019 to 2027. The report provides the overall market revenue of the global asthma treatment market for the period of 2017-2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global asthma treatment market from 2019 to 2027.

The report has been prepared after an extensive research. Primary research involves bulk of the research efforts, wherein, analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Extensive secondary research involves referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global asthma treatment market.

Secondary research includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of the top-down and bottom-up approaches to study various attributes of the global asthma treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global asthma treatment market. These serve as valuable tools for existing market players as well as for entities interested in entering in the global asthma treatment market.

The report delves into the competitive landscape of the global asthma treatment market. Key players operating in the global asthma treatment market have been identified, and each one of them has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of the players in the global asthma treatment market that have been profiled in this report.

Key Questions Answered in the Asthma Treatment Market Report

What is the sales/revenue projected to be generated by the asthma treatment market across all regions during the forecast period?

What are the opportunities in the global asthma treatment market?

What are the major drivers, restraints, opportunities, and threats in the global market?

Which region is set to expand at the fastest CAGR during the forecast period?

Which treatment type is expected to generate the highest revenue globally in 2027? Which segment is projected expand at the highest CAGR during the forecast period?

What is the market positions of different companies operating in the global market?

Global Asthma Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global asthma treatment market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study, key vendors and distributors operating in the market, and regulatory scenario for the approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that have been appropriately interspersed. Pictorial representation of the actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Asthma Treatment Market

4. Market Overview

  • 4.1. Introduction
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Asthma Treatment Market Analysis and Forecast, 2017-2027

5. Market Outlook

  • 5.1. Pipeline Analysis
  • 5.2. Reimbursement Scenario
  • 5.3. Disease Prevalence with Key Countries

6. Global Asthma Treatment Market Analysis and Forecasts, by Treatment Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Global Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017-2027
    • 6.3.1. Long-term Asthma Control Medications
      • 6.3.1.1. Inhaled Corticosteroids
      • 6.3.1.2. Leukotriene Modifiers
      • 6.3.1.3. Long-acting Beta Agonists
      • 6.3.1.4. Combination Inhalers
      • 6.3.1.5. Theophylline
      • 6.3.1.6. Others (reslizumab, benralizumab, etc.)
    • 6.3.2. Quick-relief (rescue) Medications
      • 6.3.2.1. Short-acting Beta Agonists
      • 6.3.2.2. Ipratropium (Atrovent)
      • 6.3.2.3. Oral and Intravenous Corticosteroids
  • 6.4. Global Asthma Treatment Market Attractiveness, by Treatment Type

7. Global Asthma Treatment Market Analysis and Forecasts, by Route of Administration

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Global Asthma Treatment Market Value (US$) Forecast, by Route of Administration, 2017-2027
    • 7.3.1. Oral
    • 7.3.2. Inhaled
    • 7.3.3. Intravenous
    • 7.3.4. Subcutaneous
  • 7.4. Global Asthma Treatment Market Attractiveness, by Route of Administration

8. Global Asthma Treatment Market Analysis and Forecasts, by Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Global Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Online Pharmacies
  • 8.4. Global Asthma Treatment Market Attractiveness, by Distribution Channel

9. Global Asthma Treatment Market Analysis and Forecasts, by Region

  • 9.1. Key Findings
  • 9.2. Global Asthma Treatment Market Value (US$ Mn) Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Global Asthma Treatment Market Attractiveness, by Region

10. North America Asthma Treatment Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. North America Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017-2027
    • 10.2.1. Long-term Asthma Control Medications
      • 10.2.1.1. Inhaled Corticosteroids
      • 10.2.1.2. Leukotriene Modifiers
      • 10.2.1.3. Long-acting Beta Agonists
      • 10.2.1.4. Combination Inhalers
      • 10.2.1.5. Theophylline
      • 10.2.1.6. Others (reslizumab, benralizumab, etc.)
    • 10.2.2. Quick-relief (rescue) Medications
      • 10.2.2.1. Short-acting Beta Agonists
      • 10.2.2.2. Ipratropium (Atrovent)
      • 10.2.2.3. Oral and Intravenous Corticosteroids
  • 10.3. North America Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
    • 10.3.1. Oral
    • 10.3.2. Inhaled
    • 10.3.3. Intravenous
    • 10.3.4. Subcutaneous
  • 10.4. North America Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
    • 10.4.1. Hospital Pharmacies
    • 10.4.2. Retail Pharmacies
    • 10.4.3. Online Pharmacies
  • 10.5. North America Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. North America Asthma Treatment Market Attractiveness Analysis
    • 10.6.1. By Treatment Type
    • 10.6.2. By Route of Administration
    • 10.6.3. By Distribution Channel
    • 10.6.4. By Country/Sub-region

11. Europe Asthma Treatment Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017-2027
    • 11.2.1. Long-term Asthma Control Medications
      • 11.2.1.1. Inhaled Corticosteroids
      • 11.2.1.2. Leukotriene Modifiers
      • 11.2.1.3. Long-acting Beta Agonists
      • 11.2.1.4. Combination Inhalers
      • 11.2.1.5. Theophylline
      • 11.2.1.6. Others (reslizumab, benralizumab etc.)
    • 11.2.2. Quick-relief (rescue) Medications
      • 11.2.2.1. Short-acting Beta Agonists
      • 11.2.2.2. Ipratropium (Atrovent)
      • 11.2.2.3. Oral and Intravenous Corticosteroids
  • 11.3. Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
    • 11.3.1. Oral
    • 11.3.2. Inhaled
    • 11.3.3. Intravenous
    • 11.3.4. Subcutaneous
  • 11.4. Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
    • 11.4.1. Hospital Pharmacies
    • 11.4.2. Retail Pharmacies
    • 11.4.3. Online Pharmacies
  • 11.5. Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region , 2017-2027
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Europe Asthma Treatment Market Attractiveness Analysis
    • 11.6.1. By Treatment Type
    • 11.6.2. By Route of Administration
    • 11.6.3. By Distribution Channel
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Asthma Treatment Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017-2027
    • 12.2.1. Long-term Asthma Control Medications
      • 12.2.1.1. Inhaled Corticosteroids
      • 12.2.1.2. Leukotriene Modifiers
      • 12.2.1.3. Long-acting Beta Agonists
      • 12.2.1.4. Combination Inhalers
      • 12.2.1.5. Theophylline
      • 12.2.1.6. Others (reslizumab, benralizumab etc.)
    • 12.2.2. Quick-relief (rescue) Medications
      • 12.2.2.1. Short-acting Beta Agonists
      • 12.2.2.2. Ipratropium (Atrovent)
      • 12.2.2.3. Oral and Intravenous Corticosteroids
  • 12.3. Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
    • 12.3.1. Oral
    • 12.3.2. Inhaled
    • 12.3.3. Intravenous
    • 12.3.4. Subcutaneous
  • 12.4. Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
    • 12.4.1. Hospital Pharmacies
    • 12.4.2. Retail Pharmacies
    • 12.4.3. Online Pharmacies
  • 12.5. Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region , 2017-2027
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Asia Pacific Asthma Treatment Market Attractiveness Analysis
    • 12.6.1. By Treatment Type
    • 12.6.2. By Route of Administration
    • 12.6.3. By Distribution Channel
    • 12.6.4. By Country/Sub-region

13. Latin America Asthma Treatment Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017-2027
    • 13.2.1. Long-term Asthma Control Medications
      • 13.2.1.1. Inhaled Corticosteroids
      • 13.2.1.2. Leukotriene Modifiers
      • 13.2.1.3. Long-acting Beta Agonists
      • 13.2.1.4. Combination Inhalers
      • 13.2.1.5. Theophylline
      • 13.2.1.6. Others (reslizumab, benralizumab etc.)
    • 13.2.2. Quick-relief (rescue) Medications
      • 13.2.2.1. Short-acting Beta Agonists
      • 13.2.2.2. Ipratropium (Atrovent)
      • 13.2.2.3. Oral and Intravenous Corticosteroids
  • 13.3. Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
    • 13.3.1. Oral
    • 13.3.2. Inhaled
    • 13.3.3. Intravenous
    • 13.3.4. Subcutaneous
  • 13.4. Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
    • 13.4.1. Hospital Pharmacies
    • 13.4.2. Retail Pharmacies
    • 13.4.3. Online Pharmacies
  • 13.5. Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region , 2017-2027
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Latin America Asthma Treatment Market Attractiveness Analysis
    • 13.6.1. By Treatment Type
    • 13.6.2. By Route of Administration
    • 13.6.3. By Distribution Channel
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Asthma Treatment Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017-2027
    • 14.2.1. Long-term Asthma Control Medications
      • 14.2.1.1. Inhaled Corticosteroids
      • 14.2.1.2. Leukotriene Modifiers
      • 14.2.1.3. Long-acting Beta Agonists
      • 14.2.1.4. Combination Inhalers
      • 14.2.1.5. Theophylline
      • 14.2.1.6. Others (reslizumab, benralizumab etc.)
    • 14.2.2. Quick-relief (rescue) Medications
      • 14.2.2.1. Short-acting Beta Agonists
      • 14.2.2.2. Ipratropium (Atrovent)
      • 14.2.2.3. Oral and Intravenous Corticosteroids
  • 14.3. Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
    • 14.3.1. Oral
    • 14.3.2. Inhaled
    • 14.3.3. Intravenous
    • 14.3.4. Subcutaneous
  • 14.4. Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
    • 14.4.1. Hospital Pharmacies
    • 14.4.2. Retail Pharmacies
    • 14.4.3. Online Pharmacies
  • 14.5. Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region , 2017-2027
    • 14.5.1. GCC
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Middle East & Africa Asthma Treatment Market Attractiveness Analysis
    • 14.6.1. By Treatment Type
    • 14.6.2. By Route of Administration
    • 14.6.3. By Distribution Channel
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Share Analysis, by Company (2018)
  • 15.2. Company Profiles
    • 15.2.1. AstraZeneca
      • 15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.1.2. Company Financials
      • 15.2.1.3. Growth Strategies
      • 15.2.1.4. SWOT Analysis
    • 15.2.2. Boehringer Ingelheim International GmbH
      • 15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.2.2. Company Financials
      • 15.2.2.3. Growth Strategies
      • 15.2.2.4. SWOT Analysis
    • 15.2.3. GlaxoSmithKline plc
      • 15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.3.2. Company Financials
      • 15.2.3.3. Growth Strategies
      • 15.2.3.4. SWOT Analysis
    • 15.2.4. Novartis AG
      • 15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.4.2. Company Financials
      • 15.2.4.3. Growth Strategies
      • 15.2.4.4. SWOT Analysis
    • 15.2.5. Teva Pharmaceutical Industries Ltd
      • 15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.5.2. Company Financials
      • 15.2.5.3. Growth Strategies
      • 15.2.5.4. SWOT Analysis
    • 15.2.6. Sumitomo Dainippon Pharma Co., Ltd
      • 15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.6.2. Company Financials
      • 15.2.6.3. Growth Strategies
      • 15.2.6.4. SWOT Analysis
    • 15.2.7. Merck & Co., Inc.
      • 15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.7.2. Company Financials
      • 15.2.7.3. Growth Strategies
      • 15.2.7.4. SWOT Analysis
    • 15.2.8. F. Hoffmann-La Roche Ltd.
      • 15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.8.2. Company Financials
      • 15.2.8.3. Growth Strategies
      • 15.2.8.4. SWOT Analysis
    • 15.2.9. Sanofi
      • 15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.9.2. Company Financials
      • 15.2.9.3. Growth Strategies
      • 15.2.9.4. SWOT Analysis
    • 15.2.10. Mylan N.V.
      • 15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.10.2. Company Financials
      • 15.2.10.3. Growth Strategies
      • 15.2.10.4. SWOT Analysis